XML 28 R9.htm IDEA: XBRL DOCUMENT

Composition of Certain Consolidated Financial Statement Line Items

3 Months Ended

Mar. 31, 2026

3. Composition of Certain Consolidated Financial Statement Line Items

Accrued expenses and other current liabilities consisted of the following (in thousands):



		MARCH 31,			DECEMBER 31,
		2026			2025
Accrued compensation		$	6,368		$	12,434
Accrued research and development expenses			8,349			12,404
Accrued clinical expenses			23,067			15,791
Accrued professional services			7,192			4,470
Accrued other liabilities			1,577			1,444
Total accrued expenses and other current liabilities		$	46,553		$	46,543